1/39
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
The Phosphoinositide Pathway
production of 3 2nd messengers that are involved in many pathways
the 3 secondary messengers produced are
inositol-1,4,5-trisphophate (IP3)
Ca²+
1,2-diacylglycerol (DAG)
Ligand binding results in
the cytoplasmic release of the 2nd messenger Ca²+ and IP3
Ligand binds to receptor causing activation of
hetertrimeric G protein ( GTP binds to alpha subunit)
Gqalpha-GTP diffuses laterally along plasma membrane and activates…
the membrane bound enzyme phospholipase C (PLC)
Activated PLC catalyzes the
hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2) at its glycerol-phospho bond
PLC mediated PIP2 hydrolysis yields
(IP3)
DAG
Hydrolysis of PIP2 sets in motion Both
membrane bound and cytoplasmic events
Where does Diacylglycerol (DAG) act as a 2nd messenger ?
in the membrane
Where does IP3 diffuse through?
charged and water soluble
so through the cytoplasm → ER
How does IP3 associate with Ca²+?
binds to and induces the opening of a Ca²+ transport channel in ER
efflux of Ca²+ from ER
Cytosolic [Ca²+] increases causing
muscle contraction, actin filaments
triggers glucose mobilization
Calmodulin (CaM) is a
Ca²+ activated switch
CaM
highly conserves 148- residue protein
ubiquitous
eukaryotic Ca²+ binding protein (facilitates binding)
in numerous cellular regulatory processes
CaM can function as
1) free floating monomeric protein alone
2) as a subunit of a larger protein domain
CaM has 2 structurally similar globular domains
connected by seven-turn alpha helix
each globular domain contains 2 high-affinity Ca²+ binding sites
EF Hands CaM
each Ca²+ binding site is formed by nearly superimposable helix-loop-helix motifs (EF Hands)
EF Hands form
Ca²+ binding sites in numerous other Ca²+ binding proteins
Ca²+- cAM binding to either domain of CaM induces
conformational change in that domain
functional change can block/access active site
exposed patch binds with high affinity to caM-binding domains of Ca²+-regulated protein kinases
DAG
lipid-soluble 2nd messenger
DAG location
embedded in plasma membrane
DAG activates
membrane- bound protein kinase C (PKC)
Active PCK
phosphorylates several different cellular proteins
PKC resting state
phosphorylated
cytosolic protein
DAG increases membrane affinity of
PKC
stabilizes PKCs active conformation
BOTH PKA and PKC phosphorylate
Ser and Thr residues
Phosphoinositide System is limited by
destruction of its 2nd messengers
ex: IP5 phosphotase
Inositol polyphosphate 5-phosphatse
IP3→ IP2
removal of 2nd messenger from pathway
disturbs the Ca²+ transport channel
Insulin Signaling Pathway
once insulin gets phosphorylated all proteins get phosphorylates
Insulin Binding Step 1
insulin receptor autophosphorylates itself at Tyr residues
Tyr-phosphorylates its target proteins
activating several signaling pathways
IR-P controls diverse effects: DNA/RNA/Protein Synthesis
1) phosphorylation of the adaptor protein Shc
2) phosphorylation of Gab-1
phosphorylation of the adaptor protein Shc
Shc-P generates a binding site for Grb2’s SH2 domain
stimulation of a MAP kinase cascade
affecting growth and differentiation
Phosphorylation of Gab-1
activates the MAP kinase cascade
IR-P controls diverse effects: glycogen synthesis/ glucose transport/cell growth and differentiation
Phosphorylation of insulin receptor substrate IRS proteins
Phosphorylation of insulin receptor substrate IRS proteins
activates enzymes known as PI3Ks
PI3Ks add
phophoryl group to the ‘3’-OH group of phosphatidylinositol
3-phophorylated lipid activates Protein kinase-1 (PDK1)
Activated PDK1s lead to cascades causing:
glycogen synthesis
glucose transport
cell growth and differentiation
IR-P controls diverse effects: glucose transport
4) phosphorylation of the APS/Cbl complex
phosphorylation of the APS/Cbl complex
stimulation of TC10 (monomeric G protein) and (PI3K-independent)
regulation of glucose transport involving the participation of lipid rafts
Insulin is a hormone that can trigger a variety of physiological effects which makes is not possible to be part of a
one hormone-one target regulatory system